Literature DB >> 30289800

Neurodevelopmental outcomes in HIV-infected and uninfected African children.

Pierre Debeaudrap1, Florence Bodeau-Livinec2, Estelle Pasquier3, David Germanaud4,5,6, Suzie Tetang Ndiang7, Anne Njom Nlend7, Francis Ateba Ndongo8, Georgette Guemkam8, Callixte Ida Penda9,10, Josiane Warszawski11, Diavolana Koecher12, Albert Faye4,5,13, Mathurin Cyrille Tejiokem14.   

Abstract

OBJECTIVE: HIV infection is associated with cognitive impairments, but outcomes are poorly explored in children starting antiretroviral therapy (ART) early or in those exposed but uninfected.
DESIGN: Nested cross-sectional evaluation of the neurocognitive and behavioural outcomes of HIV-infected, HIV-exposed uninfected (HEU) and HIV-unexposed (HUU) Cameroonian children at age 4-9 years prospectively followed.
METHODS: Cognitive development was assessed in 127 HIV-infected, 101 HEU, 110 HUU children using the KABC-II, neurologic dysfunction using the Touwen examination and behavioural difficulties using the Strength and Difficulties Questionnaire (SDQ). Analyses were adjusted for children age, sex and primary language. Contextual factors were included in a second step to assess their effects on outcomes.
RESULTS: All HIV-infected children were treated before 12 months. There was a negative linear gradient in KABC-II scores from HUU children to HEU and HIV-infected children [gradient: -6.0 (-7.7; -4.3) for nonverbal index, NVI, and -8.8 (-10.7; -6.8) for mental processing index, MPI]. After adjusting for contextual factors, scores of HEU children were not significantly different from those of HUU children (all P > 0.1) and differences between HIV-uninfected and HUU children reduced [NVI: from -11.9 (-15.3; -8.5) to -3.4 (-6.8; -0.01), MPI: from -17.6 (-21.3; -13.8) to -5.5 (-9.3; -1.7)]. Compared with uninfected children, HIV-infected children had more neurological dysfunctions and higher SDQ scores (P = 0.002).
CONCLUSION: Despite early ART, perinatal-HIV infection is associated with poorer neurocognitive scores and increased behavioural difficulties during childhood. Contextual factors play an important role in this association, which emphasizes the need for early nutritional and developmental interventions targeting both HIV-affected infants and their relatives.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30289800     DOI: 10.1097/QAD.0000000000002023

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

1.  African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus.

Authors:  Michael J Boivin; Miriam Chernoff; Lee Fairlie; Barbara Laughton; Bonnie Zimmer; Celeste Joyce; Linda Barlow-Mosha; Mutsawashe Bwakura-Dangarembizi; Tichaona Vhembo; Mmule Ratswana; Portia Kamthunzi; Katie McCarthy; Itziar Familiar-Lopez; Patrick Jean-Philippe; Joan Coetzee; Nasreen Abrahams; Hermien Gous; Avy Violari; Mark F Cotton; Paul E Palumbo
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

Review 2.  Contemporary Issues in Pregnancy (and Offspring) in the Current HIV Era.

Authors:  Allison Ross Eckard; Stephanie E Kirk; Nancy L Hagood
Journal:  Curr HIV/AIDS Rep       Date:  2019-12       Impact factor: 5.071

3.  Validation of the National Institute of Health Toolbox Cognition Battery (NIHTB-CB) in Children and Adolescents with and without HIV Infection in Lusaka, Zambia.

Authors:  Pelekelo P Kabundula; Esau G Mbewe; Sylvia Mwanza-Kabaghe; Gretchen L Birbeck; Milimo Mweemba; Bo Wang; J Anitha Menon; David R Bearden; Heather R Adams
Journal:  AIDS Behav       Date:  2022-04-21

4.  In utero and peripartum antiretroviral exposure as predictor of cognition in 6- to 10-year-old HIV-exposed Ugandan children - a prospective cohort study.

Authors:  A E Ezeamama; S K Zalwango; A Sikorskii; R Tuke; P M Musoke; B Giordani; M J Boivin
Journal:  HIV Med       Date:  2021-04-16       Impact factor: 3.180

5.  In utero exposure to HIV and/or antiretroviral therapy: a systematic review of preclinical and clinical evidence of cognitive outcomes.

Authors:  Megan S McHenry; Kayode A Balogun; Brenna C McDonald; Rachel C Vreeman; Elizabeth C Whipple; Lena Serghides
Journal:  J Int AIDS Soc       Date:  2019-04       Impact factor: 6.707

6.  Low risk of neurodevelopmental impairment among perinatally acquired HIV-infected preschool children who received early antiretroviral treatment in Thailand.

Authors:  Watsamon Jantarabenjakul; Weerasak Chonchaiya; Thanyawee Puthanakit; Tuangtip Theerawit; Jesdaporn Payapanon; Jiratchaya Sophonphan; Montida Veeravigom; Neda Jahanshad; Paul M Thompson; Jintanat Ananworanich; Kathleen Malee; Chitsanu Pancharoen
Journal:  J Int AIDS Soc       Date:  2019-04       Impact factor: 5.396

Review 7.  Neurocognitive deficits and socioeconomic risk factors among children and adolescents living with HIV in sub-Saharan Africa: a systematic review.

Authors:  Otsetswe Musindo; Lydiah Krabbendam; Joan Mutahi; Miguel Pérez García; Paul Bangirana; Manasi Kumar
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2022-04-27       Impact factor: 7.494

8.  Determinants of the psychomotor development delay in children aged 12 to 59 months infected with HIV in Yaounde, Cameroon.

Authors:  Ginette Claude Mireille Kalla; Ursule Larissa Temgoua Dongmo; Jules Clément Nguedia Assob; Nelly Kamgaing Noubi; Francois-Xavier Mbopi-Keou; Francisca Monebenimp
Journal:  Pan Afr Med J       Date:  2022-06-10

Review 9.  Psychiatric Disorders in Adolescents Living with HIV and Association with Antiretroviral Therapy Adherence in Sub-Saharan Africa: A Systematic Review and Meta-analysis.

Authors:  Anthony A Olashore; Saeeda Paruk; Oluyemi O Akanni; Andrew Tomita; Bonginkosi Chiliza
Journal:  AIDS Behav       Date:  2020-11-20

10.  Behavioral Functioning and Quality of Life in South African Children Living with HIV on Antiretroviral Therapy.

Authors:  Stephanie Shiau; Henry Evans; Renate Strehlau; Yanhan Shen; Megan Burke; Afaaf Liberty; Ashraf Coovadia; Elaine J Abrams; Michael T Yin; Avy Violari; Louise Kuhn; Stephen M Arpadi
Journal:  J Pediatr       Date:  2020-07-23       Impact factor: 4.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.